HUP0102607A2 - Szulfonilcsoporttal szubsztituált bifenil-metil-imidazol-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk - Google Patents
Szulfonilcsoporttal szubsztituált bifenil-metil-imidazol-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásukInfo
- Publication number
- HUP0102607A2 HUP0102607A2 HU0102607A HUP0102607A HUP0102607A2 HU P0102607 A2 HUP0102607 A2 HU P0102607A2 HU 0102607 A HU0102607 A HU 0102607A HU P0102607 A HUP0102607 A HU P0102607A HU P0102607 A2 HUP0102607 A2 HU P0102607A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- hydrogen atom
- alkyl group
- phenyl
- atom
- Prior art date
Links
- 150000002460 imidazoles Chemical class 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 7
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 2
- 229910052801 chlorine Inorganic materials 0.000 abstract 2
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 229910052740 iodine Inorganic materials 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 230000003288 anthiarrhythmic effect Effects 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A találmány szerinti antiaritmiás hatású vegyületek (I) általánosképletében R(1) jelentése hidrogénatom, alkilcsoport vagy -CaH2a-fenilképletű csoport, amely fenilrészében adott esetben szubsztituálvalehet, ahol a értéke 0, 1 vagy 2, vagy R(1) jelentése -CbH2b-heteroaril képletű csoport, amely heteroarilrészében adott esetbenszubsztituálva lehet, ahol b értéke 0, 1 vagy 2, vagy R(1) jelentése -CdH2d-cikloalkil képletű csoport, ahol d értéke 0, 1 vagy 2, R(2) ésR(3) jelentése egymástól függetlenül hidrogénatom, fluoratom,klóratom, brómatom, jódatom, trifluor-metil-csoport, cianocsoport,nitrocsoport, -CH2OR(17), -CO-R(6), -O-R(7), -O-(alkilén)-O-R(17) vagy-NR(50)R(51) általános képletű csoport, ahol R(17) jelentésehidrogénatom vagy alkilcsoport, R(6) jelentése hidrogénatom,alkilcsoport, -OR(30) általános képletű csoport vagy fenilcsoport,amely adott esetben szubsztituálva lehet, ahol R(30) jelentésehidrogénatom vagy alkilcsoport, R(50) és R(51) jelentése egymástólfüggetlenül -(alkilén)-O-R(52) általános képletű csoport, ahol R(52)jelentése hidrogénatom vagy alkilcsoport, R(7) jelentése hidrogénatom,alkilcsoport vagy fenilcsoport, amely adott esetben szubsztituálvalehet, vagy R(7) jelentése heteroarilcsoport, amely adott esetbenszubsztituálva lehet, vagy R(2) és R(3) jelentése egymástólfüggetlenül alkilcsoport, cikloalkilcsoport vagy -CgH2g-fenil képletűcsoport, amely fenilrészében adott esetben szubsztituálva lehet, aholg értéke 0, 1 vagy 2, vagy R(2) és R(3) jelentése egymástólfüggetlenül -ClH2l-heteroaril képletű csoport, amelyheteroarilrészében adott esetben szubsztituálva lehet, ahol l értéke0, 1 vagy 2, vagy R(2) és R(3)jelentése egymástól függetlenül -SOn-R(22) általános képletű csoport, ahol n értéke 0, 1 vagy 2, R(22)jelentése alkilcsoport, cikloalkilcsoport vagy -CsH2s-fenil képletűcsoport, amely fenilrészében adott esetben szubsztituálva lehet, ahols értéke 0, 1 vagy 2, R(4) és R(5)jelentése egymástól függetlenülhidrogénatom, alkilcsoport, fluoratom, klóratom, brómatom, jódatom,trifluor-metil-csoport, cianocsoport, nitrocsoport, -SOp-R(16), -CO-R(23), -O-R(24) vagy -O-(alkilén)-O-R(33) általános képletű csoport,ahol p értéke 0, 1 vagy 2, R(16) jelentése alkilcsoport vagyfenilcsoport, amely adott esetben szubsztituálva lehet, ahol R(23)jelentése hidrogénatom, alkilcsoport vagy -OR(25) általános képletűcsoport, ahol R(25) jelentése hidrogénatom vagy alkilcsoport, R(24)jelentése hidrogénatom, alkilcsoport vagy fenilcsoport, amely adottesetben szubsztituálva lehet, R(33) jelentése hidrogénatom vagyalkilcsoport, azzal a megszorítással, hogy R(2) és R(3) közül legalábbaz egyik jelentése -O-(2, 3 vagy 4 szénatomos alkilén)-O-R(17) vagy -NR(50)R(51) általános képletű csoport. A találmány kiterjed a fentivegyületek fiziológiailag alkalmazható sóira és a fenti
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19832428A DE19832428A1 (de) | 1998-07-18 | 1998-07-18 | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| PCT/EP1999/004887 WO2000003996A1 (de) | 1998-07-18 | 1999-07-10 | Imidazolderivate mit biphenylsulfonylsubstitution, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0102607A2 true HUP0102607A2 (hu) | 2002-03-28 |
| HUP0102607A3 HUP0102607A3 (en) | 2002-05-28 |
Family
ID=7874574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0102607A HUP0102607A3 (en) | 1998-07-18 | 1999-07-10 | Imidazole derivatives with sulfonyl biphenyl methyl pharmautical compositions containing them and their use |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6369236B1 (hu) |
| EP (1) | EP1097141B1 (hu) |
| JP (1) | JP4567885B2 (hu) |
| KR (1) | KR20010071957A (hu) |
| CN (1) | CN1211370C (hu) |
| AR (1) | AR019405A1 (hu) |
| AT (1) | ATE362920T1 (hu) |
| AU (1) | AU764438B2 (hu) |
| BR (1) | BR9912241A (hu) |
| CA (1) | CA2338059A1 (hu) |
| DE (2) | DE19832428A1 (hu) |
| HK (1) | HK1038743A1 (hu) |
| HU (1) | HUP0102607A3 (hu) |
| ID (1) | ID27774A (hu) |
| PL (1) | PL345585A1 (hu) |
| RU (1) | RU2246488C2 (hu) |
| TR (1) | TR200100134T2 (hu) |
| WO (1) | WO2000003996A1 (hu) |
| ZA (1) | ZA200100278B (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19832429A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832428A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| US20030220383A1 (en) * | 2002-02-14 | 2003-11-27 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the sodium-dependent chloride/bicarbonate exchanger for the treatment of thrombotic and inflammatory disorders |
| DE10206354A1 (de) * | 2002-02-14 | 2003-08-28 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des Natrium-abhängigen Chlorid-Bicarbonat-Austauschers zur Behandlung von thrombotischen und inflammatorischer Erkrankungen |
| KR101171480B1 (ko) | 2007-07-02 | 2012-08-07 | 에프. 호프만-라 로슈 아게 | Ｃｃｒ-2 수용체 길항제로서의 이미다졸 유도체 |
| US8236843B2 (en) | 2008-09-02 | 2012-08-07 | Elder Pharmaceuticals Ltd. | Anti inflammatory compounds |
| KR101044953B1 (ko) * | 2009-01-07 | 2011-06-29 | (주) 인우 코퍼레이션 | 이중분사노즐을 이용한 악취제거 시스템 |
| EP3159347A4 (en) * | 2014-06-23 | 2018-01-24 | Nissan Chemical Industries, Ltd. | Method for producing sulfonyl-bond-containing silane compound |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5126342A (en) * | 1990-10-01 | 1992-06-30 | Merck & Co., Inc. | Imidazole angiotensin ii antagonists incorporating acidic functional groups |
| CA2058198A1 (en) * | 1991-01-04 | 1992-07-05 | Adalbert Wagner | Azole derivatives, process for their preparation, and their use |
| EP0586513A1 (en) * | 1991-05-10 | 1994-03-16 | Merck & Co. Inc. | Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
| TW215434B (hu) * | 1992-03-07 | 1993-11-01 | Hoechst Ag | |
| US5310929A (en) * | 1992-08-06 | 1994-05-10 | E. I. Du Pont De Nemours And Company | Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists |
| FR2711367B1 (fr) | 1993-10-19 | 1995-12-01 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
| FR2711368B1 (fr) * | 1993-09-16 | 1996-01-05 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
| FR2716882B1 (fr) | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
| FR2716883B1 (fr) * | 1994-03-04 | 1996-04-26 | Roussel Uclaf | Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant. |
| DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| EP0855392A3 (de) * | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832428A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832429A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1998
- 1998-07-18 DE DE19832428A patent/DE19832428A1/de not_active Withdrawn
-
1999
- 1999-07-10 JP JP2000560103A patent/JP4567885B2/ja not_active Expired - Fee Related
- 1999-07-10 PL PL99345585A patent/PL345585A1/xx not_active Application Discontinuation
- 1999-07-10 EP EP99938222A patent/EP1097141B1/de not_active Expired - Lifetime
- 1999-07-10 DE DE59914347T patent/DE59914347D1/de not_active Expired - Lifetime
- 1999-07-10 KR KR1020017000752A patent/KR20010071957A/ko not_active Application Discontinuation
- 1999-07-10 US US09/743,957 patent/US6369236B1/en not_active Expired - Lifetime
- 1999-07-10 HU HU0102607A patent/HUP0102607A3/hu unknown
- 1999-07-10 BR BR9912241-3A patent/BR9912241A/pt not_active Application Discontinuation
- 1999-07-10 AU AU52807/99A patent/AU764438B2/en not_active Ceased
- 1999-07-10 ID IDW20010129A patent/ID27774A/id unknown
- 1999-07-10 CA CA002338059A patent/CA2338059A1/en not_active Abandoned
- 1999-07-10 AT AT99938222T patent/ATE362920T1/de not_active IP Right Cessation
- 1999-07-10 TR TR2001/00134T patent/TR200100134T2/xx unknown
- 1999-07-10 WO PCT/EP1999/004887 patent/WO2000003996A1/de not_active Application Discontinuation
- 1999-07-10 RU RU2001104449/04A patent/RU2246488C2/ru not_active IP Right Cessation
- 1999-07-10 CN CNB998087416A patent/CN1211370C/zh not_active Expired - Fee Related
- 1999-07-15 AR ARP990103486A patent/AR019405A1/es not_active Application Discontinuation
-
2001
- 2001-01-10 ZA ZA200100278A patent/ZA200100278B/en unknown
- 2001-12-28 HK HK01109164A patent/HK1038743A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1309645A (zh) | 2001-08-22 |
| BR9912241A (pt) | 2001-04-10 |
| EP1097141A1 (de) | 2001-05-09 |
| ID27774A (id) | 2001-04-26 |
| HK1038743A1 (en) | 2002-03-28 |
| ZA200100278B (en) | 2001-08-06 |
| CA2338059A1 (en) | 2000-01-27 |
| EP1097141B1 (de) | 2007-05-23 |
| PL345585A1 (en) | 2001-12-17 |
| DE59914347D1 (de) | 2007-07-05 |
| AU764438B2 (en) | 2003-08-21 |
| RU2246488C2 (ru) | 2005-02-20 |
| CN1211370C (zh) | 2005-07-20 |
| WO2000003996A1 (de) | 2000-01-27 |
| US6369236B1 (en) | 2002-04-09 |
| ATE362920T1 (de) | 2007-06-15 |
| KR20010071957A (ko) | 2001-07-31 |
| JP2002520399A (ja) | 2002-07-09 |
| AR019405A1 (es) | 2002-02-20 |
| TR200100134T2 (tr) | 2001-07-23 |
| DE19832428A1 (de) | 2000-01-20 |
| AU5280799A (en) | 2000-02-07 |
| JP4567885B2 (ja) | 2010-10-20 |
| HUP0102607A3 (en) | 2002-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL104614A (en) | 4-benzoylisoxazole derivatives and herbicidal compositions comprising them | |
| HUP0102607A2 (hu) | Szulfonilcsoporttal szubsztituált bifenil-metil-imidazol-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| SE8503415D0 (sv) | Novel isoindolinyl-alkyl-piperazines | |
| KR920006350A (ko) | 3-아릴-4(3h)퀴나졸리논 cck 길항물질 및 그의 약학 조성물 | |
| TR200100603T2 (tr) | Pirazin bileşikleri | |
| GB2104890B (en) | Pyridinecarbinols, their preparation and fungicides containing them | |
| AU8988782A (en) | Pyridazinone derivatives | |
| PL227048A2 (hu) | ||
| TR200401433T4 (tr) | Yeni karışımlar. | |
| ES465225A1 (es) | Procedimiento para la preparacion de n-cicloalcohilmetil-2- fenilamino-imidazolinas-(2). | |
| DE69402935T2 (de) | Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
| SE8006668L (sv) | 2-amino-3-bensoyl-fenylacetamider och cykliska homologer | |
| AU539870B2 (en) | 2-phenylamino-imidazolines-(2) | |
| ATE19068T1 (de) | Pyridinderivate, ihre herstellung und verwendung. | |
| IE782050L (en) | Thieno-piperidines | |
| DK428087A (da) | Dihydropyridin-5-phosphonsyre-cyclopropylenester | |
| AP9801328A0 (en) | Azole compounds endowed with antimycotic activity for human and veterinary use. | |
| ES472537A1 (es) | Un procedimiento para la preparacion de nuevas tiadiazolil- benzamidas | |
| ES8800663A1 (es) | Procedimiento para preparar compuestos arilsulfonicos. | |
| GR3005109T3 (hu) | ||
| IE40951L (en) | Preparation of 1, 4- diazepines. | |
| HUP0000957A2 (hu) | Szacharin-5-karbonil-ciklohexán-1,3,5-trion-származékok,ezeket tartalmazó herbicid készítmények | |
| IE782412L (en) | Benzimidazole derivatives. | |
| TH2435EX (th) | สาร 2-(2-ซับสติทิว เบนโซอิล)-1-,3-ไซโคลเฮกเซนไดโอน | |
| DK417686D0 (da) | Substituerede azolyldioxaner og azolyldioxolaner til anvendelse som fungicider samt fremgangsmaade til fremstilling af saadanne forbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |